Prostamax (20mg Vial)

01 · At a glance

Quickstart Highlights

Prostamax is a synthetic bioregulator tetrapeptide (Lys‑Glu‑Asp‑Pro) described as prostate‑tissue–specific in preclinical literature[1]. Short peptides can interact with DNA/chromatin and influence gene expression programs[2], and several ultrashort peptides show cellular uptake via peptide/amino‑acid transporters[3][4]. This educational protocol presents a once‑daily subcutaneous approach, drawing from daily parenteral schedules in animal studies and general best practices for subcutaneous peptide delivery.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3.0 mL → ~6.67 mg/mL)

Reference dose shown on this page: 6.67 mg.

Reconstitution Steps

1. Using aseptic technique, draw 3.0 mL bacteriostatic water for injection (multi‑dose diluent with benzyl alcohol) [11] .
2. Inject slowly down the vial wall; allow the powder to dissolve fully (gently swirl; do not shake).
3. Label the vial and store at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycling [12] [13] .

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Educational framework to explore prostate‑tissue support signals observed in preclinical models (reduced inflammatory and fibrotic markers) [1] .
• Schedule: Daily subcutaneous injections for 8–12 weeks (optional extension to 16 weeks).
• Dose Range: 500–3000 mcg daily with gradual titration.
• Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for clear syringe conversions.
• Storage: Lyophilized at −20 °C (−4 °F); reconstituted at 2–8 °C (35.6–46.4 °F); minimize freeze–thaw [12] [13] .

Dosing Protocol

• Suggested daily titration approach with cautious evidence framing.
• Start: 500–1000 mcg once daily; increase by ~500–1000 mcg every 1–2 weeks as tolerated.
• Target: 2000–3000 mcg once daily by Weeks 5–8.
• Rationale: Aligns with daily parenteral schedules in animal data and SC volume tolerability in adults [1] [7] .
• Timing: Any consistent time of day; rotate injection sites.

Storage Instructions

• Keep lyophilized vials cold (e.g., −20 °C [−4 °F] ) and protected from light; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid repeated freeze–thaw cycles [11] [12] [13] .
• Storage: Lyophilized at −20 °C (−4 °F); reconstituted at 2–8 °C (35.6–46.4 °F); minimize freeze–thaw [12] [13] .
• Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

• Practical considerations for consistency and safety.
• Use new sterile insulin syringes; dispose in an approved sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to minimize lipohypertrophy and variability in absorption [14] [16] .
• Subcutaneous technique: insert at 45° into subcutaneous tissue; aspiration is not required [5] [6] .
• Follow WHO/NCBI injection best‑practice guidance for asepsis and preparation [8] .

05 · How it works

How This Works

Prostamax is a synthetic bioregulator tetrapeptide (Lys‑Glu‑Asp‑Pro) described as prostate‑tissue–specific in preclinical literature[1].

Short peptides can interact with DNA/chromatin and influence gene expression programs[2], and several ultrashort peptides show cellular uptake via peptide/amino‑acid transporters[3][4].

This educational protocol presents a once‑daily subcutaneous approach, drawing from daily parenteral schedules in animal studies and general best practices for subcutaneous peptide delivery.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• Prostamax observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
• This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

09 · Evidence

References